Grudziądz, Poland – February 27, 2026 — Revival Site Network proudly announces a major milestone in its global expansion with the launch of its first-ever Phase I clinical research facility and its first research site outside of the United States. This strategic step marks the organization’s evolution into a truly global clinical research network.
The new Phase I facility is being established through a strategic partnership with Pharmbiotest Poland, combining operational expertise, scientific excellence, and regional capabilities to advance early-phase clinical development.
This collaboration strengthens Revival’s ability to support sponsors and CRO partners with expanded geographic reach, enhanced early-phase trial capabilities, and improved access to diverse patient populations across Europe.
A Strategic Step Toward Global Growth
The Poland facility represents a significant advancement in Revival Site Network’s long-term vision to connect high-quality research environments across regions while accelerating clinical development timelines.
Through this partnership, Revival Site Network will expand its global footprint while maintaining its commitment to operational excellence, regulatory compliance, and patient-focused research delivery.
What This Partnership Brings
- Dedicated facility supporting Phase I clinical trials
- Advanced study design and protocol planning capabilities
- Expanded European research presence
- Enhanced global patient access and recruitment diversity
The Phase I unit will support early-stage clinical development, including first-in-human studies, providing sponsors with integrated capabilities aligned with international quality standards.
A Milestone Moment for Revival Site Network
Mazhar Jaffry, President and CEO of Revival Site Network, expressed strong enthusiasm for this next chapter, recognizing the launch as a defining step in the organization’s growth journey.
“This expansion reflects our vision of building a connected global research network,” Jaffry shared. “Launching our first Phase I facility and our first site outside the United States is an exciting milestone as Revival Site Network continues to grow beyond borders.”
About Revival Research Institute, LLC
Revival Site Network is a collaborative clinical research site network focused on advancing medical research and improving patient outcomes. The network consists of independently owned research sites across the United States, working under a shared framework for quality, compliance, and operational excellence. Revival Site Network supports the delivery of ethical, efficient, and high-quality clinical trials across therapeutic areas.
For inquiries or more information
248-721-9539
info@rev-research.com
23999 Northwestern Hwy Southfield, MI 48075
